Krish Krishnan, Krystal Biotech CEO

Krys­tal Biotech rais­es $160M via PIPE on heels of FDA ap­proval for gene ther­a­py

Krys­tal Biotech has re­ceived $160 mil­lion in pri­vate fi­nanc­ing days af­ter the FDA ap­proved Vyju­vek, a gene ther­a­py for chil­dren with a rare skin …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.